)
)
)
FibroBiologics (Nasdaq:FBLG)
March 02, 2026
Ballroom II C
Type: Company Presentation
Focus Area:
Gene/Cell Therapy
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Year Founded:
2021
Lead Product in Development:
Diabetic Foot Ulcer, Multiple Sclerosis, Psoriasis, Human Longevity
Speakers
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
